VitriVax Inc., a Boulder-based vaccine-formulation technology company, has raised $17.25 million in Series B financing.

The updated COVID-19 vaccine is expected to be available in Singapore at selected polyclinics and private general ...

VitriVax, Inc., a vaccine formulation technology company, today announced it raised a total of $17.25 million in Series B financing. The round was co-led by Adjuvant Capital and RA Capital Management, ...

DALLAS, Oct. 14, 2025 /PRNewswire/ -- Sunoco LP (NYSE: SUN) ("Sunoco" or the "Partnership") and Parkland Corporation (TSX: PKI) ("Parkland") today announced that the Government of Canada has approved ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm ...

Ewing Morris, on behalf of investment vehicles and accounts managed by it ("Ewing Morris"), today announced the completion of its all-cash offer ...

Abstract: The product delivery process is a set of steps to transport a product of an origin to a delivery point. Nowadays, there are different platforms or software based on classical algorithms for ...

OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance Biologics, a U.S.-based Contract Development and Manufacturing Organization (CDMO), announced the launch of its in-house formulation development services, ...

The oral solution is supplied in a 120 mL bottle containing 25 mg of sitagliptin per mL. Brynovin ™, an oral solution formulation of sitagliptin, is now available from Azurity Pharmaceuticals.

The latest American Heart Association (AHA) calculator for assessing atherosclerotic cardiovascular disease (ASCVD) risk performs well in patients with high and low lipoprotein(a) levels, a new ...